Researchers deny any attempt to mislead the public over JAMA article on arthritis drugBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7308.301 (Published 11 August 2001) Cite this as: BMJ 2001;323:301
- Scott Gottlieb
- New York
Researchers at the centre of a row over data presented to JAMA, the journal of the American Medical Association, which showed the results of only the first six months of a trial of a new arthritis drug have defended their actions, following a controversial article in the Washington Post earlier this week (5 August).
The newspaper article accuses researchers of intentionally giving a prominent gastroenterologist incomplete data on the safety of a popular arthritis drug so that he might write a more favourable editorial about their study.
The editorial, published in the 13 September issue of JAMA (2000;284:1297-9) was cowritten by Dr Michael Wolfe, a gastroenterologist …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial